Skip to main content
. 2021 May 3;48(12):3886–3902. doi: 10.1007/s00259-021-05362-8

Table 2.

[18F]FDG-PET/CT characteristics in the studies

Study [18F]FDG Imaging modality Injected activity Interval [18F]FDG injection-image acquisition Scan coverage Arterial regions examined Image analysis Definition of positive [18F]FDG-PET/CT finding
Alibaz-Oner et al. (2015) PET/CT (low-dose CT) 3.7 MBq/kg 60 min Mid-skull to mid-thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, CarotCom, Subclav, Renal Visuala Visual ≥ 2a
Banerjee et al. (2020)

PET/CT (low-dose CT)

Paediatrics: PET/MRI

370 MBq

Paediatrics: 3.7 MBq/kg

120 min for PET/CT

60 min for PET/MR

Vertex to the proximal thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, Carot Subclav

1) Visual

2) PETVASa

Visual pattern consistent with vasculitis
Bruls et al. (2016) PET/CT (low-dose CT, followed by arterial phase CT 3.7 MBq/kg 60 min Skull to upper-thigh ‘Supra-aortic’, AoThor, AoAbd, Iliac Visual Any focal uptake higher than background
Castellani et al. (2016) PET/CT (low-dose CT) 199–478 MBq 50–60 min Mid-skull to distal lower extremities ‘Supra-aortic’, AoThor, AoAbd, Iliofem

1) Visual

2) Total visual score 11 aortic tree regions

3) TBR (SUVmean artery/SUVmean liver)

4) Mean TBR 11 aortic tree regions

Calculated cutoff

12 for total visual score and 0.653 for mean TBR 11 aortic tree regions

De Boysson et al. (2017) PET/CT (low-dose CT) 4 MBq/kg 60 ± 5 min Whole body AoThor, AoAbd, Carot, Subclav, Axil, Iliofem, ‘upper and lower limb arteries’ Visuala Visual = 3a
Grayson et al. (2018)

PET/CT(low-dose CT)

Paediatrics: PET/MRI

370 MBq

Paediatrics: 3.7 MBq/kg

120 min Vertex to mid-thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, Carot, Subclav, Axil, Iliac, Fem

1) Nuclear medicine physician global assessment

2) Visual

3) PETVASa

Visual pattern consistent with vasculitis
Henes et al. (2011) PET/CT (low-dose CT) Not reported 60 min Mid-skull to knee/mid-thigh (presumably) AoAsc/AoArch, AoDesc, AoAbd, CarotCom, Subclav/Axil, IliacCom, FemSup Visuala Visual ≥ 2a
Incerti et al. (2017) PET/CT (low-dose CT) 370 MBq 60 min Vertex to mid-thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, CarotCom, Subclav, Axil, Humeral, Renal, IliacCom, Fem, Popliteal

1) Visual

2) SUVmax

Visual uptake equal to or higher than liver
Lee et al. (2012) PET/CT(low-dose CT) 370 MBq 40–60 min Mid-skull to mid-thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, CarotCom, Subclav, IliacCom

1) Visuala

2) TBR (SUVmax artery/SUVmax liver)

Visual ≥ 2a
Li et al. (2019) PET/CT (low-dose CT) 37 MBq/13 kg 60 min Only carotid artery CarotCom Visuala Visual ≥ 2a
Martínez-Rodríguez et al. (2018) PET/CT (low-dose CT) 7 MBq/kg 180 min Whole body ‘Entire aortic wall’ TBR (SUVmax artery/SUVmax blood pool) Not reported for the relevant disease monitoring scans
Nielsen et al. (2018) PET/CT (low-dose CT)

Baseline scan: 5 MBq/kg

Second scan: 200 MBq

60 min

Baseline scan:

Skull to mid-thigh

Second scan:

Limited field of view (minimum neck and thorax)

AoAsc, AoArch, AoDesc, Carot, SubclavAsc, SubclavDesc, Axil, Vertebral

1) Visuala

2) TBR (SUVmax artery/SUVmean venous)

Visual ≥ 3a
Park et al. (2018) PET/CT (low-dose CT) 5.18 MBq/kg 60 min Skull to proximal thigh or whole-body AoAsc, AoArch AoDesc, AoAbd., Innom, CarotCom, Subclav, Iliac

1) Visuala

2) PETVAS

3) SUVmax

4) TBR (SUVmax artery/SUVmean vein)

5) TBR (SUVmax artery/SUVmean liver)

Visual ≥ 2a
Quinn et al. (2018)

PET/CT (low-dose CT)

Paediatrics: PET/MRI

370 MBq

(presumably)

Not reported Not reported AoAsc, AoArch, AoDesc, AoAbd, Innom, Carot, Subclav, Axil, Iliac, Fem

1) Visual

2) PETVASa

Visual uptake higher than liver
Regola et al., (2020) PET/CT (low-dose CT) Not reported Not reported Not reported AoAsc, AoArch, AoDesc, AoAbd, Innom, Carot, Subclav

1) PETVASa

2) TBR (SUVmax artery/SUVmax liver)

Not reported for the relevant disease monitoring scans
Rimland et al. (2020)

PET/CT (low-dose CT)

Paediatrics: PET/MRI

370 MBq 120 min Vertex to mid-thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, Carot, Subclav PETVASa Not reported for the relevant disease monitoring scans
Sammel et al. (2020) PET/CT (low-dose CT) 100 MBq 60 min Vertex to diaphragm (head/neck/horax) AoAsc, AoArch, AoDesc, Innom, Carot, Subclav, Axil, Temporal, Occipital, Maxillary, Vertebral Total vascular score 18 arterial regions b Not reported for the relevant disease monitoring scans
Santhosh et al. (2014) PET/CT (low-dose CT) 370 MBq 60 min Skull base to mid-thigh AoAsc, AoArch, AoDesc, AoAbd, Innom, CarotCom, Subclav, Brachial, Pulmonary, Superior mesenteric, IliacCom Visual Visual = 3 in ascending aorta, visual ≥ 2 aortic arch, any uptake descending/abdominal aortaa
Schramm et al. (2019)

PET/CT (low-dose CT or contrast-enhanced CT)

PET without CT

3 MBq/kg 60 min Skull base to proximal thigh AoAsc, AoArch, AoDesc, AoAbd TBR (SUVmax artery/SUVmean of the liver, inferior vena cava, superior vena cava or right atrium) Not reported for the relevant disease monitoring scans
Tezuka et al. (2012) PET/CT (low-dose CT) 3.7 MBq/kg 60 min Vertex to mid-thigh AoAsc, AoArch, AoDesc, Innom, Carot, Subclav, Renal

1) SUVmax artery

2) TBR (SUVmax artery/SUVmean inferior vena cava)

Not reported for the relevant disease monitoring scans
Vitiello et al. (2018) PET/CT (low-dose CT) 3.7 MBq/kg 60 min Vertex to mid-thigh (presumably) AoThor, AoAbd, Carot, Subclav, Iliac, Fem

1) Visual

2) SUVmean

Visual pattern consistent with vasculitis

Information on image analysis is focussed on data relevant to treatment monitoring as reported in Table 3 and Supplemental Table 2. AoAbd, abdominal aorta; AoArch, aortic arch; AoAsc, ascending aorta; AoDesc, descending aorta; AoThor, thoracic aorta; Axil, axillary artery; Carot, carotid artery; CarotCom, common carotid artery; Fem, femoral artery; IliacCom, common iliac artery; Iliofem, iliofemoral artery; Innom, innominate (brachiocephalic) artery; PETVAS, PET vascular activity score (sum of visual scores in different arterial regions). Subclav, subclavian artery; SubclavAsc, ascending subclavian artery; SubclavDesc, descending subclavian artery; TBR, target to background ratio

aVisual 0, no uptake; visual 1, uptake lower than liver; visual 2, FDG uptake equal to the liver; visual 3, FDG uptake more than liver present

bVisual 0, no uptake; visual 1, minimal/equivocally increased uptake; visual 2, moderate/clearly increased uptake; visual 3, very marked uptake (no comparison to the liver was made)